Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.

Piena, Marjanne A; Kroep, Sonja; Simons, Claire; Fenwick, Elisabeth; Harty, Gerard T; Wong, Schiffon L; van Hout, Ben A

Piena, Marjanne A; Kroep, Sonja; Simons, Claire; Fenwick, Elisabeth; Harty, Gerard T; Wong, Schiffon L; van Hout, Ben A.

Afiliación

Piena MA; MMA, Evidence & Access, OPEN Health, Rotterdam, Netherlands.
Kroep S; MMA, Evidence & Access, OPEN Health, Rotterdam, Netherlands.
Simons C; MMA, Evidence & Access, OPEN Health, York, UK.
Fenwick E; MMA, Evidence & Access, OPEN Health, Oxford, UK.
Harty GT; The Healthcare Business of Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany. Gerard.Harty@merckgroup.com.
Wong SL; EMD Serono, Billerica, MA, USA.
van Hout BA; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

Adv Ther ; 39(2): 909, 2022 Feb.

Article en En | MEDLINE | ID: mdl-34997918

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google